Literature DB >> 18667193

The effect of newly diagnosed undifferentiated connective tissue disease on pregnancy outcome.

Arsenio Spinillo1, Fausta Beneventi, Oscar M Epis, Laura Montanari, Deborah Mammoliti, Veronique Ramoni, Elena Di Silverio, Claudia Alpini, Roberto Caporali, Carlomaurizio Montecucco.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate pregnancy outcome in a cohort of patients with newly diagnosed undifferentiated connective tissue disease (UCTD). STUDY
DESIGN: We conducted a nested case-control study that compared 41 patients who had early UCTD that was diagnosed at 11-14 weeks of pregnancy with 82 healthy control subjects.
RESULTS: During pregnancy, UCTD progressed to a definite connective tissue disease in 2 of 41 patients (4.9%). Sixteen of the 41 patients (39%) with UCTD tested positive for anti-Ro (SSA) antibodies. Compared with the control subjects, the women with UCTD had higher rates of small for gestational age (SGA; 12/40 vs 11/80; P = .05). The rate of complications of pregnancy (preterm delivery at </= 37 weeks of gestation, SGA, preeclampsia, late fetal loss) was 39% (16/41) among cases and 13.4% (11/82) in control subjects (adjusted odds ratio, 3.98; 95% CI, 1.59-9.49).
CONCLUSION: Pregnant patients with UCTD are at increased risk of SGA and complications of pregnancy.

Entities:  

Mesh:

Year:  2008        PMID: 18667193     DOI: 10.1016/j.ajog.2008.05.008

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study.

Authors:  Arsenio Spinillo; Fausta Beneventi; Elena Locatelli; Vèronique Ramoni; Roberto Caporali; Claudia Alpini; Giulia Albonico; Chiara Cavagnoli; Carlomaurizio Montecucco
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-18       Impact factor: 3.007

2.  Pregnancy Outcomes in Undifferentiated Connective Tissue Disease Compared to Systemic Lupus Erythematosus: A Single Academic Center's Experience.

Authors:  Katherine P Kaufman; Amanda M Eudy; Nathaniel Harris; Laura Neil; Megan E B Clowse
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-07-13       Impact factor: 5.178

3.  A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial.

Authors:  Shaoying Yang; Ruoning Ni; Yikang Lu; Suli Wang; Feng Xie; Chunyan Zhang; Liangjing Lu
Journal:  Trials       Date:  2020-09-09       Impact factor: 2.279

Review 4.  Undifferentiated Connective Tissue Disease in Pregnancy: A Topic Yet to be Explored.

Authors:  Caterina Serena; Sara Clemenza; Serena Simeone; Sara Zullino; Serena Ottanelli; Marianna Pina Rambaldi; Silvia Vannuccini; Felice Petraglia; Federico Mecacci
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

5.  A case of gestational gigantomastia in a 37-years-old woman associated with elevated ANA: a casual linkage?

Authors:  Nicola Zingaretti; Fabrizio De Biasio; Michele Riccio; Nastassia Nardini; Laura Mariuzzi; Pier Camillo Parodi
Journal:  Pan Afr Med J       Date:  2017-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.